학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 28건 | 목록 1~10
Academic Journal
Pusch FF; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Dorado García H; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Xu R; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Gürgen D; Experimental Pharmacology and Oncology (EPO), Berlin, Germany.; Bei Y; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Brückner L; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück-Centrum für Molekulare Medizin (BIMSB/BIH), Berlin, Germany.; Röefzaad C; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; von Stebut J; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Bardinet V; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Chamorro Gonzalez R; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Eggert A; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Schulte JH; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, University Hospital Tübingen, Tübingen, Germany.; Hundsdörfer P; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Helios Klinikum Berlin-Buch, Berlin, Germany.; Seifert G; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Haase K; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Schäfer BW; University Children's Hospital, Zurich, Switzerland.; Wachtel M; University Children's Hospital, Zurich, Switzerland.; Kühl AA; iPATH.Berlin-Core Unit Immunopathology for Experimental Models, Charité Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Ortiz MV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, New York.; Wengner AM; Bayer AG, Berlin, Germany.; Scheer M; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Henssen AG; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück-Centrum für Molekulare Medizin (BIMSB/BIH), Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Academic Journal
Bothe U; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Günther J; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Nubbemeyer R; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Siebeneicher H; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Ring S; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Bömer U; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Peters M; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Rausch A; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Denner K; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Himmel H; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Sutter A; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Terebesi I; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Lange M; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Wengner AM; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Guimond N; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Thaler T; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Platzek J; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Eberspächer U; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Schäfer M; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Steuber H; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Zollner TM; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Steinmeyer A; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.; Schmidt N; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Sartori G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Gaudio E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Mascia M; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Barreca M; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy.; Arribas AJ; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Licenziato L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Veterinary Sciences, University of Turin, Turin, Italy.; Golino G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Ferragamo A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Pileri S; Division of Diagnostic Haematopathology, European Institute of Oncology, Milan, Italy.; Damia G; Laboratory of Molecular Pharmacology, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.; Zucca E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Stathis A; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, USI, Lugano, Switzerland.; Politz O; Bayer AG, Pharmaceuticals, Research & Development, Berlin, Germany.; Wengner AM; Bayer AG, Pharmaceuticals, Research & Development, Berlin, Germany.; Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Academic Journal
Sundararajan V; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Tan TZ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Genomics and Data Analytics Core (GeDaC), Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Lim D; Department of Pathology, National University Hospital, Singapore, Singapore.; Peng Y; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Wengner AM; Bayer AG, Pharmaceuticals, Berlin, Germany.; Ngoi NYL; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.; Jeyasekharan AD; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Tan DSP; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE
Academic Journal
Karlsson J; Bayer AS, Oslo, Norway.; Schatz CA; Bayer AG, Berlin, Germany.; Wengner AM; Bayer AG, Berlin, Germany.; Hammer S; Bayer AG, Berlin, Germany.; Scholz A; Bayer AG, Berlin, Germany.; Cuthbertson A; Bayer AS, Oslo, Norway.; Wagner V; Bayer Consumer Care AG, Basel, Switzerland.; Hennekes H; Bayer AG, Berlin, Germany.; Jardine V; Bayer PLC, Reading, United Kingdom.; Hagemann UB; Bayer AG, Berlin, Germany.
Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Academic Journal
Dorado García H; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; Pusch F; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Bei Y; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; von Stebut J; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Ibáñez G; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Guillan K; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Imami K; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; Gürgen D; Experimental Pharmacology and Oncology (EPO), Berlin, Germany.; Rolff J; Experimental Pharmacology and Oncology (EPO), Berlin, Germany.; Helmsauer K; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Meyer-Liesener S; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Charité Campus Buch, Lindenberger Weg 80, 13125, Berlin, Germany.; Timme N; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Bardinet V; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Chamorro González R; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; MacArthur IC; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Chen CY; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Schulz J; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Wengner AM; Bayer AG, Berlin, Germany.; Furth C; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Lala B; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Eggert A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Seifert G; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Hundsoerfer P; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Kirchner M; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; Berlin Institute of Health, 10178, Berlin, Germany.; Mertins P; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; Berlin Institute of Health, 10178, Berlin, Germany.; Selbach M; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; Lissat A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Dubois F; Institute of pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, Charitéplatz 1, 10117, Berlin, Germany.; Horst D; Institute of pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Schulte JH; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Spuler S; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Charité Campus Buch, Lindenberger Weg 80, 13125, Berlin, Germany.; Berlin Institute of Health, 10178, Berlin, Germany.; Department of chemistry, biochemistry and pharmacy, Free University of Berlin, Berlin, Germany.; You D; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Dela Cruz F; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Kung AL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Haase K; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; DiVirgilio M; Max Delbrück Center for Molecular Medicine, Berlin, Germany.; Scheer M; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Ortiz MV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Henssen AG; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany. henssenlab@gmail.com.; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany. henssenlab@gmail.com.; Max Delbrück Center for Molecular Medicine, Berlin, Germany. henssenlab@gmail.com.; Berlin Institute of Health, 10178, Berlin, Germany. henssenlab@gmail.com.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany. henssenlab@gmail.com.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Böhnke N; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Berger M; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Griebenow N; Bayer AG, Pharmaceuticals, Wuppertal 42113, Germany.; Rottmann A; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Erkelenz M; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Hammer S; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Berndt S; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Günther J; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Wengner AM; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Stelte-Ludwig B; Bayer AG, Pharmaceuticals, Wuppertal 42113, Germany.; Mahlert C; Bayer AG, Pharmaceuticals, Wuppertal 42113, Germany.; Greven S; Bayer AG, Pharmaceuticals, Wuppertal 42113, Germany.; Dietz L; Bayer AG, Pharmaceuticals, Wuppertal 42113, Germany.; Jörißen H; Bayer AG, Pharmaceuticals, Wuppertal 42113, Germany.; Barak N; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Bömer U; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Hillig RC; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Eberspaecher U; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Weiske J; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Giese A; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Mumberg D; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Nising CF; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Weinmann H; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.; Sommer A; Bayer AG, Pharmaceuticals, Berlin 13353, Germany.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9010319 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4812 (Electronic) Linking ISSN: 10431802 NLM ISO Abbreviation: Bioconjug Chem Subsets: MEDLINE
Academic Journal
Berger M; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Wortmann L; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Buchgraber P; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Lücking U; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Zitzmann-Kolbe S; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Wengner AM; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Bader B; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Bömer U; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Briem H; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Eis K; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Rehwinkel H; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Bartels F; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Moosmayer D; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Eberspächer U; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Lienau P; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Hammer S; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Schatz CA; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Wang Q; Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.; Wang Q; WuXi AppTec (Wuhan) Co., Ltd., 666 Gaoxin Road, East Lake High-tech Development Zone, Wuhan 430075, P. R. China.; Mumberg D; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Nising CF; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.; Siemeister G; Research & Development, Pharmaceuticals, Bayer AG, Berlin 13353, Germany.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Yap TA; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Tan DSP; National University Cancer Institute and National University Hospital and Cancer Science Institute, National University of Singapore, Singapore.; Terbuch A; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom.; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.; Caldwell R; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom.; Guo C; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom.; Goh BC; National University Cancer Institute and National University Hospital and Cancer Science Institute, National University of Singapore, Singapore.; Heong V; National University Cancer Institute and National University Hospital and Cancer Science Institute, National University of Singapore, Singapore.; Haris NRM; Translational and Clinical Research Institute, Newcastle University and Northern Centre for Cancer Care, Newcastle, United Kingdom.; Bashir S; Translational and Clinical Research Institute, Newcastle University and Northern Centre for Cancer Care, Newcastle, United Kingdom.; Drew Y; Translational and Clinical Research Institute, Newcastle University and Northern Centre for Cancer Care, Newcastle, United Kingdom.; Hong DS; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Meric-Bernstam F; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wilkinson G; Bayer AG, Berlin, Germany.; Hreiki J; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey.; Wengner AM; Bayer AG, Berlin, Germany.; Bladt F; Bayer AG, Berlin, Germany.; Schlicker A; Bayer AG, Berlin, Germany.; Ludwig M; Bayer AG, Berlin, Germany.; Zhou Y; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey.; Liu L; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey.; Bordia S; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey.; Plummer R; Translational and Clinical Research Institute, Newcastle University and Northern Centre for Cancer Care, Newcastle, United Kingdom.; Lagkadinou E; Bayer AG, Berlin, Germany.; de Bono JS; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom. Johann.deBono@icr.ac.uk.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Wengner AM
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어